Qiming Venture Partners is a prominent venture capital firm based in Shanghai, China, with additional offices in Beijing, Suzhou, and Hong Kong. Founded in 2006, the firm specializes in investing in early to growth-stage companies across various sectors, including healthcare, information technology, consumer products, media, and clean technology. Qiming has established itself as a leading investment firm in China, managing multiple funds with over $1 billion in assets. The firm focuses on supporting innovative entrepreneurs and companies that demonstrate high growth potential, particularly in the technology and healthcare landscapes. Through its strategic investments, Qiming aims to foster the development of new business models and technologies, contributing to the dynamic entrepreneurial ecosystem in China.
Hochuen Medical, founded in 2015 by Dr. Robin Liu and Eric Zeng, specializes in contract development and manufacturing, focusing on microfluidic chips and biomedical consumables. The company leverages the extensive management experience of its founders, who have over 20 years in the fields of in vitro diagnostics (IVD), microfluidics, and electronics manufacturing. Hochuen Medical produces a range of in vitro diagnostic products, including microfluidic biochips, disposable consumables for IVD, point-of-care testing kits, life science research consumables, gene sequencing chips, and detection cards for animal, plant, and food safety testing. The company is committed to providing clients with high-quality, end-to-end contract manufacturing solutions, drawing on its expertise in research and production management.
Eco Polymer specializes in designing and manufacturing plastic tubes and parts. They provide products for polyethylene, polypropylene, polyamine, elastomers, fluoropolymers, and other various polymers. They serve the medical instrument, auto, electronics, fiber optics, semiconductor, chemical engineering, environment, and analytics industries.
Gaugene provides hematology testing instruments, reagents, and services for IVD users. Gaugene is a high-tech enterprise co-sponsored by core technology management backbones of well-known domestic IVD companies with rich management experience who master the industry’s top technologies.
LaNova Medicines is a clinical-stage innovative drug research and development company. The company focuses on the unmet therapeutic needs in the field of tumor immunity and tumor microenvironment and focuses on the research and development of "world's first" and "best-in-class" potential bio-innovative drugs.
Boulder Care, Inc. is a telemedicine-based platform focused on treating opioid addiction through a combination of medication and peer support. Founded in 2017 and located in Portland, Oregon, the company provides comprehensive services that include patient support, medication management, and psychosocial services. By leveraging digital health technology, Boulder Care aims to improve access to effective treatment for individuals struggling with opioid use, enhancing the experience for both patients and their care teams. The organization serves a diverse clientele, including patients, providers, and various health organizations, contributing to the advancement of the behavioral health industry.
Founded in 2019 by former Snap engineers, Risa Feng and Shawn Lin, Singapore-headquartered BUD is a leading global metaverse UGC platform encouraging users to create and share 3D interactive experiences with its easy-to-use creation tools. Since its global launch in November 2021, BUD skyrocketed to the list of top 10 social apps in more than 38 countries around the world including North America, Southeast Asia and South America. Millions of 3D content has been created and traded on the platform. BUD has become a digital social hub where millions of people come to create, play and hangout.
Eco Polymer specializes in designing and manufacturing plastic tubes and parts. They provide products for polyethylene, polypropylene, polyamine, elastomers, fluoropolymers, and other various polymers. They serve the medical instrument, auto, electronics, fiber optics, semiconductor, chemical engineering, environment, and analytics industries.
Developer of contract research organization (CRO) platform for medical companies. The company focuses on the integration of CRO with Internet technology, big data, artificial intelligence and other advanced technologies, enabling medical companies to shorten the drug development cycle, improve the quality of clinical data and reduce research and development costs.
Zhangjiagang Onechip Bio-Technology Co.,Ltd. develops and manufactures new generations of biochemical sensor chips and nanomaterials for various applications. It offers pH chip, such as nano-electrodes; biochips; and nanometer materials, including oil absorption and sustained release products and battery protection products. The company’s products are based on the nanoscale electronic biochemical sensors and nanomaterial technologies. It sells its products online. Zhangjiagang Onechip Bio-Technology Co.,Ltd. was founded in 2014 and is based in Zhangjiagang, China.
MeetFuture China is a technology-driven company that supplies automated transmission systems for the pan-semiconductor industry. It provides automation solutions for leading companies in the semiconductor field since 2016 and provided a highly advantageous overall for industrial upgrading and development with independent and controllable core technologies.
Medilink Therapeutics
Series B in 2022
MediLink Therapeutics has established its R&D center in Suzhou, China. The company focuses on developing next generation drug conjugates, and aims to serve the vast unmet medical needs in China, and create global value through conducting multicenter clinical trials and cross-border collaborations.
Shanghai ZhenGe Biotechnology Co., Ltd. is a research and development company that specializes in the creation of drugs and protein therapeutics. Founded in 2017 and based in Shanghai, China, the company focuses on various aspects of drug development, including mammalian cell line development, upstream and downstream processing, and formulation development. Zhenge Biotech also offers contract development and manufacturing services, as well as assistance with regulatory filings such as IND and BLA. Additionally, the company provides a research platform for antibody development, transient infection processes, N-Glycosylation, and CAR-T technologies. Through these services, Zhenge Biotech supports the pharmaceutical industry in advancing innovative therapeutic solutions.
CureGenetics is a healthcare company focused on the research and development of gene editing technologies and molecular diagnostics. It specializes in creating innovative medicines aimed at providing advanced treatments for cancers and genetic diseases. By developing a gene editing solution and a delivery platform, CureGenetics aims to enhance therapeutic options and improve patient outcomes in the field of genetic medicine.
Korro Bio Inc. specializes in the development of nucleic acid-based therapeutics aimed at targeting specific sequences in genetic code, with a focus on treating rare diseases. Founded in 2018 and located in Cambridge, Massachusetts, the company utilizes a proprietary platform that enables efficient and selective RNA editing by leveraging natural processes found in multi-cellular organisms. This innovative approach allows Korro Bio to edit messenger RNA and recode specific codons, facilitating targeted modifications in protein structure and function across various tissues.
Guangzhou Tungee Technology Co., Ltd., established in 2016 and headquartered in Panyu, China, specializes in providing intelligent sales solutions through its software as a service (SaaS) platform. The company offers a comprehensive suite of tools for enterprises, including leads mining, business opportunity engagement, customer relationship management, and order analysis, all powered by advanced technologies such as artificial intelligence, natural language processing, and machine learning algorithms. Tungee has built an extensive database covering 100 million enterprises, enabling its clients to efficiently identify, contact, and manage customers. By improving the accuracy of sales leads and reducing customer acquisition costs, Tungee enhances sales efficiency and performance. The company has served over 3,000 enterprise clients, including notable names like Alibaba and China Mobile, establishing itself as a leader in the intelligent sales sector in China.
Infinity Stones is a Silicon Valley-based company that provides cloud management services and security solutions for blockchains. They are blockchain infrastructure architects with proven track records in the industry. Their team is composed of tech leads, management experts, and financial professionals from tech giants like Google, Oracle, and Intel. Infinity Stones is currently hosting nodes for high net worth individuals, institutional investors, foundations, and universities and research institutions. They make sure every investment with us is secure, and investors can expect returns with consistency. It was founded in 2018 and is headquartered in Palo Alto, California.
DPTechnology, founded in 2018 and based in Beijing, China, specializes in micro-scale industrial design through advanced molecular simulation technology. The company has developed a platform that integrates artificial intelligence with molecular simulation algorithms, aiming to enhance industrial and medical research. By providing users with innovative scientific tools, DPTechnology promotes efficiency and creativity in exploring complex research challenges, thereby establishing a new paradigm in both industrial research and clinical applications.
Cornerstone Robotics is dedicated to enhancing the accessibility of advanced medical services in China through the development of medical robotic devices. The company is focused on creating a safe and efficient surgical robotics platform aimed at improving the accuracy and efficiency of surgical operations. By prioritizing research and development, Cornerstone Robotics enables physicians to perform surgeries with greater precision, ultimately contributing to better patient outcomes in the healthcare sector.
Platelet BioGenesis is a biotechnology company focused on producing donor-independent human platelets from pluripotent stem cells for clinical use. Founded in 2014 and based in Cambridge, Massachusetts, the company has developed a microfluidic bioreactor that enables the generation of functional platelets at commercial scale from human stem cell cultures. Platelet BioGenesis distributes these bioreactor-produced platelets to hospitals and blood banks, aiming to provide a reliable source of platelets for patients worldwide. By specializing in the fields of platelets and drug discovery, the company is addressing critical needs in the medical community related to blood supply and treatment options.
Okeanos Technology specializes in the custom synthesis and production of specialized chemical biological reagents and pharmaceutical intermediates tailored for the life sciences sector. The company's primary offerings include modified nucleotides, unnatural amino acids, heterocycles, and fluorescent and labeling reagents. Okeanos supplies these products to leading pharmaceutical companies, earning a strong reputation for quality and reliability. The firm focuses on providing clients with a diverse range of chemical compounds and biochemical reagents, particularly in the realms of sequencing and synthetic biology.
Genlight is a company based in Hangzhou, China, that specializes in developing advanced treatment solutions for epilepsy and other neurological disorders. The organization focuses on innovative technologies in the field of brain science and neurosurgery, creating laser medical equipment designed to improve patient outcomes. Genlight's offerings include brain-computer control technology, deep brain nerve stimulation with full-cranial implantation, brain computer chips, and a minimally invasive surgery system guided by magnetic resonance. These high-tech solutions aim to provide patients with effective and cutting-edge surgical options for neurological conditions.
ShouTi specializes in the discovery and development of drugs against a type of targets called GPCR. The company develops drugs focused on novel small molecules for multiple unmet medical needs. ShouTi is currently operating in Stealth mode.
Ventyx Biosciences, Inc. is a biotechnology company based in Encinitas, California, focused on developing selective inhibitors of TYK2 for the treatment of autoimmune diseases. Incorporated in 2018, the company boasts a diverse portfolio of innovative clinical and pre-clinical programs aimed at high-value therapeutic targets. Through its research and development efforts, Ventyx is committed to advancing treatments that address unmet medical needs in the autoimmune disease space.
Alamar Biosciences develops technologies for the detection and treatment of cancer and other diseases at the earliest possible time. The company was founded in 2018 and is headquartered in Hayward, California.
Moody Tiger is an international activewear brand established in 2018, focusing on functional and fashionable athleisurewear for children aged 4 to 14 years. The company specializes in developing high-tech fabrics that ensure comfort and quality, catering to the needs of active children. By combining style with practicality, Moody Tiger aims to provide a range of fashion-forward activewear options that appeal to both children and their parents.
Developer of intelligent medical devices designed for treatment of Parkinson and motor dysfunction. With research and development of intelligent monitoring and assistant devices, the company develops systematic systematic solutions to functional disorders for patients with Parkinson and motor dysfunction, enabling patients to monitor their physical activities and facilitate their movements.
Zuoshouyisheng's AI doctor platform spans 35 medical specialties and can diagnose more than 6,000 diseases, according to the company’s website. Zuoshouyisheng mainly collaborates with customers through a SaaS business model, providing its AI-empowered healthcare system to hospitals, pharmaceutical companies, employers, and insurers.
Abogen Biosciences
Series C in 2021
Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based (RNA and DNA) therapeutics for treatment of cancer and infectious diseases.
Berry Oncology is a medical technology company focused on enhancing cancer prevention and diagnosis through advanced genomic testing solutions. The company offers a range of products and services, including genetic diagnosis, companion diagnostics, and tools for monitoring treatment response and prognosis prediction for various malignant tumors. By addressing clinical challenges associated with cancer detection and management, Berry Oncology aims to facilitate early diagnosis and treatment, ultimately improving patient quality of life and reducing cancer risks. Its mission emphasizes precise treatment for all patients, while its vision seeks to establish the company as a leader in early screening and diagnosis within the global market, particularly in China's tumor gene testing sector.
Kingsware specializes in developing a robotic process automation system. It is committed to building an enterprise-level safe robot management platform. Its product follows the design concept of safe, easy-to-use, powerful, stable, and efficient, and the system can be deployed and controlled in a large-scale, highly integrated enterprise complex environment.
Guangzhou WeRide Technology Co., Ltd. develops autonomous driving technology for level 4 AD cars. The company also develops own AD hardware solution to fit on cars for surround sensor coverage and full spectrum. The company was founded in 2017 and is headquartered in Guangzhou, China.
InSilico Medicine, Inc. is an artificial intelligence company focused on drug discovery, biomarker development, and aging research. Founded in 2014 and headquartered in Baltimore, Maryland, the company employs advanced AI technologies, including deep learning and generative adversarial networks, to create novel molecular structures for diseases with known and unknown targets. Its comprehensive platform covers all stages of drug development, from discovery to clinical trials. Key initiatives include Pharma.AI, which offers machine learning services to various industries, and Young.AI, which predicts biological age. InSilico Medicine also engages in internal drug discovery programs targeting conditions such as cancer, Parkinson's Disease, and age-related disorders. Additionally, the company has partnered with Life Extension to develop nutraceutical products using its bioinformatics and deep learning techniques. Through its innovative solutions, InSilico Medicine aims to enhance personalized healthcare and mitigate the effects of aging.
Developer of Tumor-treating Fields technology. The company's products are focused on delivering diagnostic and minimally invasive treatment tools for various brain cancers, enabling healthcare professionals to more effectively treat patients.
Beijing Health Biotech Co. Ltd. specializes in the development of diagnostic and therapeutic products aimed at the diagnosis, treatment, and monitoring of Alzheimer's disease. Founded in 2016 and based in Beijing, the company employs advanced mass spectrometry technology, specifically liquid chromatography-mass spectrometry, to facilitate early diagnosis and treatment. Its product offerings include a range of diagnostic tests for various conditions, including Alzheimer's disease, cardiovascular disease, and genetic metabolic disorders. In addition, the company provides therapeutic drug monitoring, neonatal genetic metabolic disease screening, and clinical testing services. Through its innovations, Health Biotech seeks to aid healthcare professionals in enhancing patient outcomes, particularly in improving cognitive abilities and delaying the onset of Alzheimer's disease.
Hope Medicine focuses on researching, developing, and commercializing innovative biopharmaceuticals aimed at enhancing the quality of life for patients with various prevalent diseases. The company specializes in translational medicine, utilizing insights from global research initiatives to create monoclonal antibodies, protein drugs, and other therapeutic options targeting endocrine, cardiovascular, and metabolic disorders. By addressing the needs of underserved patient populations, Hope Medicine strives to improve health outcomes and provide access to effective and affordable treatments.
Just Medical is a developer and manufacturer of orthopedic medical devices, specializing in artificial orthopedic implants and systems. The company is dedicated to research and development in orthopedics, producing a range of products including artificial hip joints, artificial knee joints, internal fixation devices, and orthopedic surgical instruments. By focusing on advanced technology, Just Medical aims to enhance the quality of orthopedic treatment and improve surgical efficiency for healthcare providers and their patients.
Yidao Biotechnology (Suzhou) Co., Ltd., established in 2017 and based in Suzhou, China, specializes in the research and development of biomedicine, with a particular emphasis on vaccines. The company focuses on creating a diverse range of vaccine types, including recombinant protein antigen vaccines, new virus vector vaccines, messenger RNA vaccines, and vaccine adjuvant platforms. Yidao Biotechnology aims to address the health needs of both domestic and international markets through its innovative vaccine solutions.
Guangzhou Tungee Technology Co., Ltd., established in 2016 and headquartered in Panyu, China, specializes in providing intelligent sales solutions through its software as a service (SaaS) platform. The company offers a comprehensive suite of tools for enterprises, including leads mining, business opportunity engagement, customer relationship management, and order analysis, all powered by advanced technologies such as artificial intelligence, natural language processing, and machine learning algorithms. Tungee has built an extensive database covering 100 million enterprises, enabling its clients to efficiently identify, contact, and manage customers. By improving the accuracy of sales leads and reducing customer acquisition costs, Tungee enhances sales efficiency and performance. The company has served over 3,000 enterprise clients, including notable names like Alibaba and China Mobile, establishing itself as a leader in the intelligent sales sector in China.
P&R Measurement Technology Co., Ltd., established in 2011 and based in Zhuhai, China, specializes in the research, development, and application of advanced measurement and control technology. The company provides testing and automation solutions across various sectors, including motors, household appliances, consumer electronics, and energy power. With over 300 independent intellectual property rights, P&R Measurement has earned recognition as a national high-tech enterprise and has received multiple certifications, including ISO9001:2015. The firm focuses on engineering signal processing, acoustic and vibration testing, and structural analysis, offering custom and semi-custom testing equipment and consulting services. P&R Measurement also collaborates with universities and research institutions to enhance its technological capabilities. It operates subsidiaries in multiple locations, including Guangzhou, Suzhou, Hong Kong, and the United States, and has developed comprehensive solutions that are widely acknowledged by industry clients, contributing to its reputation in the testing and automation landscape.
Tasogare Coffee is a Japan-based company that specializes in distributing high-quality coffee products. The company focuses on bringing Japanese drip filter bag coffee into the Chinese market, catering to the growing demand for accessible and premium coffee options. Tasogare's product lineup includes capsule espresso liquids, freeze-dried coffee, and various other coffee offerings, enabling Chinese consumers to enjoy affordable and high-quality coffee in their homes.
SinoUnited Health is a medical center based in Shanghai, China, specializing in sports medicine, physical therapy, pain management, orthopaedics, and neurology services. Established in 2004, the center offers a comprehensive range of treatments, including services for foot and ankle issues, acupuncture, chronic pain management, movement disorders, migraines, tremors, electromyography, balance training, and post-stroke care. The facility is designed to provide a comfortable environment that meets international standards, ensuring a high-quality experience for patients. SinoUnited Health has built a strong reputation for delivering reliable diagnoses and effective treatment outcomes, reinforcing its commitment to enhancing patient satisfaction and well-being within the community.
CastBox operates a spoken audio platform that allows users to find, access, create, and enjoy a wide variety of spoken audio content, including podcasts, on-demand radio, and audiobooks. Founded in 2016 and headquartered in Beijing, with additional offices in Hong Kong and San Francisco, the platform is accessible via mobile devices, desktops, and smart home devices. CastBox employs proprietary technology, including curated podcast recommendations and an in-audio deep search feature, which enhances the user experience by delivering personalized content based on individual listening habits. The platform supports multiple languages and offers a free download option, enabling users to listen to audio content anytime and anywhere. Using natural language processing and machine learning algorithms, CastBox effectively transcribes spoken audio and tailors search results to meet user preferences.
Matrixport is a comprehensive platform that facilitates the trading, custody, investment, and borrowing of cryptocurrency assets. Headquartered in Singapore, the company leverages advanced technology and industry expertise to provide a range of services, including digital currency trading, institutional custody, and cryptocurrency lending. Matrixport's mission is to foster a more open and equitable financial system by utilizing blockchain technologies. With a focus on client empowerment, the platform aims to offer innovative financial products to users worldwide, thereby enabling them to take control of their finances and capital.
Booming Tech is a cloud-based platform that specializes in game development and virtual reality. It provides tools for creators to design and innovate within virtual environments, catering to various applications, including gaming, industrial simulations, and other immersive experiences. The platform features a robust server architecture that ensures players can engage in real-time, stable interactions regardless of their geographical locations. By focusing on both entertainment and practical applications, Booming Tech supports a diverse range of virtual world creation, enabling users to explore new possibilities in digital interaction.
Zion Pharma
Series B in 2021
Zion is a leading drug discovery platform that develops "me-better" drugs that address true unmet needs.
Alpha Biopharma Inc. is a biopharmaceutical company based in Huangpu, China, focused on the research and development of innovative therapeutics. The company is actively developing AZD3759, a small molecule tyrosine kinase inhibitor aimed at treating patients with non-small cell lung cancer who have epidermal growth factor receptor (EGFR) mutations and central nervous system metastases. Alpha Biopharma collaborates with prominent domestic and international pharmaceutical companies to enhance the reliability of its product development. The company employs a strong scientific consulting and management team to optimize its drug development strategies, emphasizing a comprehensive approach that includes research, market positioning, and intellectual property protection. Additionally, Alpha Biopharma partners with top contract research organizations, contract manufacturing organizations, hospitals, and institutes to ensure efficient and organized program implementation, supported by a robust project management system.
Abogen Biosciences
Series B in 2021
Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based (RNA and DNA) therapeutics for treatment of cancer and infectious diseases.
Icosavax, Inc. is a biotechnology company based in Seattle, Washington, founded in 2017. It specializes in the development of vaccines using computationally designed virus-like particles (VLPs). The company's primary focus is on creating safe and effective vaccines to address significant unmet medical needs in the realm of infectious diseases, particularly life-threatening respiratory illnesses. One of its key vaccine candidates is IVX-121, aimed at protecting older adults from respiratory syncytial virus (RSV) disease. Icosavax leverages exclusive technology licensed from the Institute for Protein Design at the University of Washington to advance its innovative vaccine solutions.
imToken Pte. Ltd. is a Singapore-based company that specializes in developing a blockchain-based cryptocurrency wallet and digital asset management tools. Founded in 2016, imToken enables users to manage multi-chain assets and facilitates secure token exchanges within its wallet. The platform features a DApp browser that supports decentralized token-to-token transactions, enhancing the user experience in the blockchain ecosystem. Over the years, imToken has garnered a global user base, becoming one of the largest Ethereum wallets in the world. The company operates as a subsidiary of Hangzhou Rongshi Technology Co., Ltd. and is dedicated to making blockchain technology accessible and user-friendly for a broader audience.
Shanghai ZhenGe Biotechnology Co., Ltd. is a research and development company that specializes in the creation of drugs and protein therapeutics. Founded in 2017 and based in Shanghai, China, the company focuses on various aspects of drug development, including mammalian cell line development, upstream and downstream processing, and formulation development. Zhenge Biotech also offers contract development and manufacturing services, as well as assistance with regulatory filings such as IND and BLA. Additionally, the company provides a research platform for antibody development, transient infection processes, N-Glycosylation, and CAR-T technologies. Through these services, Zhenge Biotech supports the pharmaceutical industry in advancing innovative therapeutic solutions.
Developer and operator of an online insurance and medical portal platform intended to serve the rural communities in China. The company's platform allows users to pay for insurance online, create reimbursement plans, and identify disease types online, providing easy access to insurance and online medical services for rural communities in China. The company utilizes government funding and resources to subsidize insurance and medical bills, alleviating poverty caused by medical challenges in rural communities.
Cool Academy
Series B in 2021
Cool College is a Beijing-based software-as-a-service(SaaS) developer for employee training services.
Beijing Yuanbao Technology Co., Ltd. is a technology company founded in 2018 and based in Beijing, China. It specializes in cyber security by offering a range of services including cyber security assessment consulting, network security detection, and cyber security insurance solutions. Yuanbao Tech provides enterprises with risk monitoring and evaluation services aimed at reducing the likelihood of cyber security risks. The company also assists insurance and reinsurance firms by developing models and technical services for cyber security insurance products, as well as conducting risk assessments for their insured clients. Through its integrated solutions, Yuanbao Tech plays a crucial role in enhancing network security management for businesses.
Weier Technology Co., Ltd, also known as Weier Science, designs and develops robots and software. Its human- machine interaction technology caters e-commerce platforms with customer service, sales and marketing, shopping guide, and customer relations management. Weier Technology Co., Ltd was founded in 2016 and is based in Hangzhou, China. Weier Technology operates in the augmented reality and virtual reality industry. The company is based in Shanghai, China.
Newsoara
Venture Round in 2021
Newsoara is a biomedical technology developer that specializes in the development of medical devices.
Singular Medical is a technology company specializing in R&D and industrialization of cardiac rhythm management (CRM) products. The company builds a complete technical platform and is a supplier of full line of CRM products, which provides a complete range of solutions, from detection to follow-up for large amounts of cardiac patients.
Plum is an e-commerce platform for second-hand fashion products. It works as a one-stop consignment service platform that provides filming, sales, customer service, sale, and a full set of consignment services. Plum was founded on 2015 and is headquartered in Beijing, China.
MoreWis is an enterprise service provider that specializes in cloud manufacturing execution systems. Its solutions cater to various industries, including surface-mounted technology, electronic assembly, green energy battery solutions, and smart factory applications. By offering advanced tools for data analytics and real-time monitoring, MoreWis helps clients enhance their production processes and operational efficiency.
Bouffalo Lab is a semiconductor chip design company based in Shanghai, China, specializing in the development of integrated Wi-Fi chipsets and a comprehensive range of Internet of Things (IoT) solutions. The company's products are tailored for applications in smart homes, smart cities, manufacturing, robotics, communication equipment, and intelligent systems for vehicles and wearables. Bouffalo Lab's chips are designed to support low-power wireless microcontrollers and application processor platforms, enabling efficient and high-performance operation across various sectors.
Guangzhou WeRide Technology Co., Ltd. develops autonomous driving technology for level 4 AD cars. The company also develops own AD hardware solution to fit on cars for surround sensor coverage and full spectrum. The company was founded in 2017 and is headquartered in Guangzhou, China.
Vistel is a technology-based firm that focuses on the use of artificial intelligence (AI) in the medical field. Vistel was founded in 2016 by Sun Yuhui and Ding Dayong.
Kira Pharmaceuticals is a biotechnology company founded in 2017 and based in Suzhou, China. The company specializes in the development of complement-targeted therapies and antibody drugs aimed at treating immune-mediated diseases. Kira Pharmaceuticals focuses on research, development, and production of innovative antibody therapies that provide improved treatment options for patients with complement-mediated conditions. By targeting immune modulation, the company strives to offer transformative solutions to enhance patient care and outcomes in various disease areas.
Insight Lifetech Co., Ltd. is a Chinese company focused on the development and manufacturing of medical equipment for heart intervention. The firm specializes in creating high-quality devices designed to enhance the diagnosis and therapy of cardiovascular diseases. By utilizing innovative technologies, Insight Lifetech aims to provide reliable precision in medical treatments, ultimately enabling healthcare professionals to save and improve patients' lives.
dMed Company Limited, also known as dMed Biopharmaceutical Co., Ltd., is a clinical contract research organization based in Shanghai, China. Established in 2016, dMed specializes in offering a comprehensive range of services to support the development of medicines and medical devices. Its offerings include consulting, clinical operations, biostatistics and programming, data management, pharmacovigilance, clinical science and medical affairs, quality assurance, and regulatory affairs and strategy. The company serves a diverse clientele, including biopharmaceutical and medical device companies, and aims to establish itself as a prominent international brand in the field of drug innovation services and solutions.
Nice Tuan is an e-commerce platform that specializes in providing daily groceries and a variety of household products. The company collaborates with local residential communities to source items from nearby warehouses and producers, ensuring a wide selection of fresh produce and essential goods for residents. By focusing on creating a convenient and efficient community e-commerce ecosystem, Nice Tuan aims to enhance the shopping experience for local consumers while supporting local suppliers.
Elevation Oncology, Inc. is a biotechnology company dedicated to creating precision medicines for patients with genomically defined cancers. Founded in 2019 and headquartered in New York, the company focuses on developing targeted therapies that inhibit specific genetic alterations associated with cancer progression. Its lead candidate, seribantumab, is designed to address tumor growth driven by NRG1 fusions and is currently undergoing clinical evaluation in the Phase 2 CRESTONE study, which includes patients with various tumor types exhibiting this genomic alteration. Through its innovative approach, Elevation Oncology aims to enhance treatment options for individuals with solid tumors linked to specific genetic drivers.
Shenzhen Zego Technology Co., Ltd. is a company based in Shenzhen, China, that specializes in real-time cloud streaming services for audio and video communications. Founded in 2015, Zego offers a comprehensive platform that supports various functionalities, including one-to-one video calls, live broadcasting, and multi-party video conferencing. The platform also provides services for real-time audio streaming, voice chatrooms, and recording and archiving of events such as bank account openings and interviews. Zego targets enterprise and mobile application developers, focusing on delivering stable and high-quality voice and video services across diverse sectors, including social media, online education, and telemedicine. Additionally, the company provides a software development kit (SDK) to facilitate the integration of its services into other applications.
Broncus Medical develops innovative diagnostic and therapeutic navigation technologies aimed at treating lung diseases. The company offers a range of products, including the Archimedes System, which features bronchoscopic trans-parenchymal needle access for virtual bronchoscopic planning and navigation, and the Lungpoint Virtual Bronchoscopic Navigation system that enables real-time navigation within the lungs for biopsy procedures. Additionally, Broncus is advancing its Exhale product line, which includes the Airway Bypass procedure, a minimally-invasive treatment for homogeneous emphysema, a prevalent form of the disease. The company is currently conducting the pivotal EASE Trial to evaluate this treatment. Founded in 1997 and originally named Broncus Technologies, the company is headquartered in San Jose, California, with additional operations in Shanghai, China, and Mountain View, California. Broncus Medical focuses on addressing the unmet medical needs in interventional pulmonology, improving the diagnosis and treatment of lung cancer and chronic obstructive pulmonary disease (COPD).
Talaris Therapeutics, Inc. is a biotechnology company focused on developing innovative cell therapies aimed at eliminating chronic immunosuppression in organ transplant recipients. Its lead product, FCR001, is designed to enable living donor kidney transplant recipients to discontinue all long-term immunosuppression therapy within twelve months of their transplant. Additionally, the company's technology facilitates the safe administration of hematopoietic stem cells from unmatched and unrelated donors for bone marrow transplants, minimizing the risks associated with traditional methods. Founded in 1988 and based in Louisville, Kentucky, with an office in Wellesley, Massachusetts, Talaris Therapeutics has transitioned from its former name, Regenerex, Inc., in March 2019. The company is currently in the late stages of clinical development, also exploring applications for patients with severe autoimmune and immune-mediated disorders.
Shanghai PETKIT Network Technology Co., Ltd., founded in 2013, specializes in developing and manufacturing innovative pet care products. Based in Shanghai, China, the company offers a diverse range of smart devices designed to enhance the health and well-being of pets. Its product lineup includes smart feeders, antibacterial bowls, drinking fountains, and pet monitoring devices that track activity levels, calorie consumption, and overall health. Additionally, Petkit provides a mobile application that integrates with its smart devices, allowing pet owners to monitor their pets' behaviors and health metrics conveniently. By combining technology with pet care, Petkit aims to simplify pet management for owners while ensuring the welfare of their animals.
Shukun (Beijing) Network Technology Co., Ltd. operates as an artificial intelligence based medical technology company. It offers CareSphere Advisor that includes CoronaryDoc, a coronary heart disease intelligent auxiliary diagnosis system; FFRDoc, an intelligent blood flow reserve fraction CT-FFR measurement system; CACScoreDoc for calculating calcification points; and AortaDoc, an aortic intelligent diagnosis system. The company was founded in 2017 and is based in Beijing, China with a branch in Shanghai.
Suzhou Connect Biopharmaceuticals, Ltd., a clinical-stage company, discovers and develops novel medicines for the treatment of autoimmune diseases and inflammation. Its products in pipeline includes CBP-307, an orally-active, second-generation S1P1 agonist for the treatment of a range of autoimmune diseases, including inflammatory bowel disease, graft-versus-host disease, psoriasis, and multiple sclerosis; CBP-174 for allergic rhinitis and atopic dermatitis; and CBP-201, a novel monoclonal antibody for the treatment of atopic dermatitis, asthma, and other types of allergic inflammation. The company is headquartered in Taicang, China with operations in Melbourne and San Diego.
Antengene Corporation is a biopharmaceutical company based in Shanghai, China, founded in 2016. The company specializes in developing innovative oncology therapies aimed at treating various types of cancer. Its product pipeline includes ATG-008, an orally available mTOR kinase inhibitor for advanced solid tumors and hematological malignancies, and ATG-010, a compound targeting the XPO1 protein for hematologic cancers like multiple myeloma. Additionally, Antengene is advancing several other candidates in different stages of development, including ATG-016, ATG-527, and ATG-019, which target various oncological conditions. The company is committed to addressing unmet medical needs in Asia through its research and development efforts focused on anti-tumor and anti-cancer therapies.
Guangzhou Tungee Technology Co., Ltd., established in 2016 and headquartered in Panyu, China, specializes in providing intelligent sales solutions through its software as a service (SaaS) platform. The company offers a comprehensive suite of tools for enterprises, including leads mining, business opportunity engagement, customer relationship management, and order analysis, all powered by advanced technologies such as artificial intelligence, natural language processing, and machine learning algorithms. Tungee has built an extensive database covering 100 million enterprises, enabling its clients to efficiently identify, contact, and manage customers. By improving the accuracy of sales leads and reducing customer acquisition costs, Tungee enhances sales efficiency and performance. The company has served over 3,000 enterprise clients, including notable names like Alibaba and China Mobile, establishing itself as a leader in the intelligent sales sector in China.
Shukun (Beijing) Network Technology Co., Ltd. operates as an artificial intelligence based medical technology company. It offers CareSphere Advisor that includes CoronaryDoc, a coronary heart disease intelligent auxiliary diagnosis system; FFRDoc, an intelligent blood flow reserve fraction CT-FFR measurement system; CACScoreDoc for calculating calcification points; and AortaDoc, an aortic intelligent diagnosis system. The company was founded in 2017 and is based in Beijing, China with a branch in Shanghai.
Nice Tuan is an e-commerce platform that specializes in providing daily groceries and a variety of household products. The company collaborates with local residential communities to source items from nearby warehouses and producers, ensuring a wide selection of fresh produce and essential goods for residents. By focusing on creating a convenient and efficient community e-commerce ecosystem, Nice Tuan aims to enhance the shopping experience for local consumers while supporting local suppliers.
LetsGetChecked is an at-home health testing platform that connects customers to regulated laboratory testing to better manage and control one's individual health. LetsGetChecked is making healthcare and diagnostics open and patient-led, empowering people to use technology in a simple yet powerful way. This offers consumers greater control over their individual health. LetsGetChecked is headquartered in New York, NY, with tests covering general wellness, sexual health, women's health and men's health, and is available nationwide, as well as in Canada and Europe.
Pratilipi is a storytelling platform that connects readers and writers in multiple Indian languages. It provides a space for authors to share their stories, poems, and books, allowing millions of users to discover, read, and engage with content in their preferred language and format. By facilitating the sharing of narratives, Pratilipi fosters a vibrant community where users can express themselves and enjoy diverse stories online. The platform caters to a wide audience, making literature accessible and enjoyable for individuals across different backgrounds and preferences.
Luc Therapeutics, founded in 2010 and based in Cambridge, Massachusetts, was a precision neuroscience company focused on developing novel allosteric modulators for ion channels aimed at improving neuronal firing regularity. The company specialized in creating subunit-selective NMDA receptor modulators, including NR2B negative allosteric modulators for depression and NR2B positive allosteric modulators to enhance cognitive function in schizophrenia. Additionally, it explored NR2A negative allosteric modulators to address disease progression and symptoms in Rett syndrome and other autism spectrum disorders. Luc Therapeutics was known for its innovative approach to restoring cognitive and motor functions in patients with serious neurological conditions by leveraging target specificity, patient selection, and drug optimization. In October 2017, Luc Therapeutics changed its name to Cadent Therapeutics.
Yunyinggu Technology Co., Ltd. is a Chinese start-up focused on the development and promotion of innovative display technologies aimed at enhancing the performance of flat panel displays. The company has created a proprietary solution recognized for achieving superior pixel density, or high pixels per inch (PPI), which can be utilized across various types of flat panels, including LCD, LED, and OLED displays. By advancing display technology, Yunyinggu seeks to contribute to the evolving landscape of visual performance in consumer electronics.
Belief Biomed
Debt Financing in 2020
Belief Biomed brings the latest research achievements in precision medicine in Triangle area into production and promotes international collaboration by connecting established investors from China to explore the vast opportunity of North Carolina.
Pratilipi is a storytelling platform that connects readers and writers in multiple Indian languages. It provides a space for authors to share their stories, poems, and books, allowing millions of users to discover, read, and engage with content in their preferred language and format. By facilitating the sharing of narratives, Pratilipi fosters a vibrant community where users can express themselves and enjoy diverse stories online. The platform caters to a wide audience, making literature accessible and enjoyable for individuals across different backgrounds and preferences.
Weiqiang Medical Technology develops vascular intervention technology for the treatment of aneurysm. Weiqiang Medical Technology specializes in researching and developing innovative vascular dilation products including aortic stent graft system, intraoperative stent system, peripheral vascular stent, and other supporting medical devices, aiming to provide advanced, effective medical solutions for the complicated treatments of various aortic vascular diseases.
Abbisko Therapeutics Co. Ltd. discovers, develop, and manufactures immuno-oncology therapies. It offers ABSK011 and ABSK021, which are molecule inhibitors for treating hepatocellular carcinoma; and CSF1R for the treatment of solid tumors. The company also develops therapeutics for the treatment of cancer, tumor, and diabetes, metabolic diseases, liver diseases, viral infections and CNS diseases. The company was founded in 2016 and is based in is based in Shanghai, China.
Element Science, Inc. is a medical device and digital health company focused on developing solutions for high-risk cardiovascular patients. The company's flagship product is a patch-based wearable cardioverter defibrillator that continuously monitors heart activity to protect against sudden cardiac death. This device integrates advanced data science and machine learning algorithms with strict electromechanical medical device standards, creating a proprietary digital platform that enhances patient care as individuals transition from hospital to home. Founded in 2011 and headquartered in San Francisco, California, Element Science aims to address critical health needs and reduce hospitalization rates associated with heart disease. The company was previously known as Revive Defibrillation Systems, Inc. before adopting its current name in 2014.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.